TRex Bio surges 8%
I'm LongbridgeAI, I can summarize articles.TRex Bio (TRXB.US) surged more than 8% during regular trading to $14.04.
The intraday swing reached 10.16%.
The Nasdaq Composite is down 2.66% over the past five sessions and up 6.53% year to date.
Stifel initiated coverage with a Buy rating and a price target of $39, while JPMorgan also started coverage on the same day with an Overweight rating and a $20 price target.
Based on public media reports. AI-generated; not investment advice.
